Boyer M, Sebbag E, Collongues N, Florens N, Storck W, El-Aatmani A, Walther J, Castelain V, Mariaseelan S, Grass L, Sibilia J, Gottenberg JE, Scherlinger M

Rheumatology (Oxford). 2026 09 7;:

Prescription of Targeted Therapies in patient with a history of cancer.

Sebbag E, Gottenberg JE

Joint Bone Spine. 2026 04 30;:106068

Acute myocarditis after switching between two adalimumab biosimilars.

Subervie T, Sauer F, Von Hunolstein JJ, Sebbag E, Etienne D, Storck W, Gottenberg JE, Sibilia J, Scherlinger M

Rheumatology (Oxford). 2026 03 16;:

Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series.

Scherlinger M, Dieudonné Y, Hilliquin S, Chatelus E, d'Alessandro R, Gies V, Nespola B, Martin T, Gottenberg JE, Simand C, El Aatmani A, Brandely-Piat ML, Sebbag E, Decroocq J, Sibilia J, Allanore Y, Avouac J

Ann Rheum Dis. 2026 03 5;:

Transcutaneous auricular vagus nerve stimulation versus sham stimulation in patients with erosive hand osteoarthritis (ESTIVAL): a randomised, multicentre, double-blind, sham-controlled trial.

Courties A, Tuffet S, Cormier G, Roux CH, Ornetti P, Pers YM, Gottenberg JÉ, Lespessailles E, Chapurlat R, Arniaud D, Rannou F, Wendling D, Eymard F, Mathieu S, Richette P, Saraux A, Marotte H, Poursac N, Rat AC, Bastard JP, Fellahi S, Henrotin Y, Minssen L, Deprouw C, Nguyen C, Touati A, Bérard L, Rousseau A, Simon T, Maheu E, Berenbaum F, Sellam J

Lancet Rheumatol. 2025 12 8;:

Advancing medical training with augmented reality and haptic feedback simulator: outcomes of a randomized controlled trial on lumbar puncture.

Felten R, Bigaut K, Wirth T, Kremer L, Gauer L, Arnold C, Ollivier I, Godet J, Scherlinger M, Dubois M, Sebbag E, De Sèze J, Gottenberg JE

BMC Med Educ. 2025 08 30;25(1):1231

Sarcoidosis revealed by recurrent dactylitis.

Subervie T, Willaume T, Maazouzi A, Gottenberg JE, Sibilia J, Weingertner N, Sebbag E, Scherlinger M

Arthritis Rheumatol. 2025 08 17;:

Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial.

Morel J, Dernis E, Roux C, Richez C, Brocq O, Fautrel B, Salliot C, Vittecoq O, Mariette X, Lioté F, Lassoued S, Gaujoux-Viala C, Constantin A, Soubrier M, Devauchelle-Pensec V, Goeb V, Gottenberg JE, Marotte H, Moulard AR, Daien C, Mouterde G, Lukas C, Pissarra J, Huguet H, Launay O, Galtier F, Picot MC, ,

Lancet Rheumatol. 2025 07 29;:

Maintenance of remission after tocilizumab withdrawal in patients with glucocorticoid-dependent polymyalgia rheumatica.

Chevet B, Souki A, Nowak E, Carvajal-Alegria G, Dernis E, Richez C, Truchetet ME, Wendling D, Toussirot E, Perdriger A, Gottenberg JE, Felten R, Fautrel B, Lohse A, Chiche L, Hilliquin P, Le Henaff C, Dervieux B, Direz G, Chary-Valckenaere I, Cornec D, Guellec D, Marhadour T, Saraux A, Devauchelle-Pensec V

Arthritis Rheumatol. 2025 05 7;:

Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo- controlled, double-blind trial.

Ruyssen-Witrand A, Brusq C, Masson M, Bongard V, Salliot C, Poiroux L, Nguyen M, Roux CH, Richez C, Saraux A, Vergne-Salle P, Morel J, Flipo RM, Piperno M, Gottenberg JE, Marotte H, Soubrier M, Gossec L, Dieudé P, Lassoued S, Zabraniecki L, Couture G, Boyer JF, Jamard B, Degboe Y, Constantin A

Ann Rheum Dis. 2025 01;84(1):49-59

2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.

Sebbag E, Lauper K, Molina-Collada J, Aletaha D, Askling J, Gente K, Bertheussen H, Bitoun S, Bolek EC, Burmester GR, Canhão HM, Chatzidionysiou K, Curtis JR, Danlos FX, Guimarães V, Hetland ML, Iannone F, Kostine M, Kragstrup TW, Kvien TK, Regierer AC, Schulze-Koops H, Silva-Fernández L, Szekanecz Z, Buch MH, Finckh A, Gottenberg JE

Ann Rheum Dis. 2024 12 20;:

Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.

Sebbag E, Molina-Collada J, Ndoye R, Aletaha D, Askling J, Gente K, Bertheussen H, Bitoun S, Bolek EC, Buch MH, Burmester GR, Canhão HM, Chatzidionysiou K, Curtis JR, Danlos FX, Guimarães V, Hetland ML, Iannone F, Kostine M, Kragstrup TW, Kvien TK, Regierer AC, Schulze-Koops H, Sedmak N, Silva-Fernández L, Szekanecz Z, Lauper K, Finckh A, Gottenberg JE

Ann Rheum Dis. 2024 12 20;:

Subset of DN Memory B Cells Expressing Low Levels of Inhibitory Receptor BTLA Is Enriched in SLE Patients.

Aubergeon L, Felten R, Gottenberg JE, Dumortier H, Monneaux F

Cells. 2024 12 13;13(24):

Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo-controlled, double-blind trial.

Ann Rheum Dis. 2024 10 29;:

Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren's disease.

Felten R, Foray AP, Schneider P, Marquet C, Pecquet C, Monneaux F, Dumortier H, Sibilia J, Valette F, Chatenoud L, Gottenberg JE

RMD Open. 2024 08 28;10(3):

iPSCs chondrogenic differentiation for personalized regenerative medicine: a literature review.

Ali EAM, Smaida R, Meyer M, Ou W, Li Z, Han Z, Benkirane-Jessel N, Gottenberg JE, Hua G

Stem Cell Res Ther. 2024 06 26;15(1):185

Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR Cohort.

Felten R, Fabacher T, Sedmak N, Sibilia J, Sordet C, Chatelus E, Berenbaum F, Combe B, Ruyssen-Witrand A, Vittecoq O, Meyer N, Gottenberg JE

J Clin Med. 2024 03 26;13(7):

Concordance and agreement between different activity scores in polymyalgia rheumatica.

D'Agostino J, Souki A, Lohse A, Carvajal Alegria G, Dernis E, Richez C, Truchetet ME, Wendling D, Toussirot E, Perdriger A, Gottenberg JE, Felten R, Fautrel B, Chiche L, Hilliquin P, Le Henaff C, Dervieux B, Direz G, Chary-Valckenaere I, Cornec D, Guellec D, Marhadour T, Nowak E, Saraux A, Devauchelle-Pensec V

RMD Open. 2024 03 15;10(1):

Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis.

Moulin D, Millard M, Taïeb M, Michaudel C, Aucouturier A, Lefèvre A, Bermúdez-Humarán LG, Langella P, Sereme Y, Wanherdrick K, Gautam P, Mariette X, Dieudé P, Gottenberg JE, Jouzeau JY, Skurnik D, Emond P, Mulleman D, Sellam J, Sokol H

Ann Rheum Dis. 2023 11 24;:

In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case-control study.

Pijnenburg L, Giannini M, Bouchard-Marmen M, Arnaud L, Barsotti S, Bellando-Randone S, Bernardi L, Bini P, Blagojevic J, Codullo V, Couderc M, De Moreuil C, Dernis E, Diamanti L, Dubost JJ, Duval F, Emmi G, Galempoix JM, Geny B, Gottenberg JE, Groza M, Guffroy A, Guichard I, Guilpain P, Hervier B, Hudson M, Iaccarino L, Iannone F, Lebrun D, Marchioni E, Mariampillai K, Maurier F, Mosca M, Nadaj-Pakleza A, Nannini C, Piot JM, Prieto-González S, Poursac N, Rouanet E, Sellam J, Selva-O'Callaghan A, Séverac F, Sibilia J, Sole G, Soulages A, Terrier B, Tournadre A, Troyanov Y, Vernier N, Vesperini V, Viallard JF, Ziane R, Cavagna L, Meyer A

RMD Open. 2023 09;9(3):

Evaluating the Portability of Rheumatoid Arthritis Phenotyping Algorithms: A Case Study on French EHRs.

Fabacher T, Sauleau EA, Leclerc Du Sablon N, Bergier H, Gottenberg JE, Coulet A, Névéol A

Stud Health Technol Inform. 2023 05 18;302:768-772

Refining inflammatory myopathies incidence and characteristics: a quadruple source capture-recapture survey using 2017 ACR/EULAR criteria.

Debrut L, Giannini M, Klein D, Spielmann L, Mertz P, Martin T, Nadaj-Pakleza A, Hirschi S, Nespola B, Lannes B, Terzic J, Hinschberger O, Dervieux B, Lipsker D, Arnaud L, Gottenberg JE, Kleinmann JF, Geny B, Séverac F, Velten M, Sibilia J, Meyer A

Arthritis Rheumatol. 2023 05 16;:

Alteration of innate lymphoid cell homeostasis mainly concerns salivary glands in primary Sjögren's syndrome.

Kawka L, Felten R, Schleiss C, Fauny JD, Le Van Quyen P, Dumortier H, Monneaux F, Gottenberg JE

RMD Open. 2023 05;9(2):

Bruton's tyrosine kinase (BTK) gene overexpression is associated with risk of lymphoma in primary Sjögren's syndrome.

Duret PM, Schleiss C, Kawka L, Meyer N, Ye T, Saraux A, Devauchelle-Pensec V, Seror R, Larroche C, Perdriger A, Sibilia J, Vallat L, Fornecker LM, Nocturne G, Mariette X, Gottenberg JE

Arthritis Rheumatol. 2023 04 28;:

Identification of new candidate drugs for primary Sjögren's syndrome using a drug repurposing transcriptomic approach.

Felten R, Ye T, Schleiss C, Schwikowski B, Sibilia J, Monneaux F, Dumortier H, Jonsson R, Lessard C, Ng F, Takeuchi T, Mariette X, Gottenberg JE

Rheumatology (Oxford). 2023 03 3;:

Inclusion body myositis and Sjögren's syndrome: the association works both ways.

Giannini M, Felten R, Gottenberg JE, Geny B, Meyer A

Acta Neuropathol Commun. 2022 10 24;10(1):152

Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.

Devauchelle-Pensec V, Carvajal-Alegria G, Dernis E, Richez C, Truchetet ME, Wendling D, Toussirot E, Perdriger A, Gottenberg JE, Felten R, Fautrel BJ, Chiche L, Hilliquin P, Le Henaff C, Dervieux B, Direz G, Chary-Valckenaere I, Cornec D, Guellec D, Marhadour T, Nowak E, Saraux A

JAMA. 2022 09 20;328(11):1053-1062

Variability in primary Sjögren's syndrome is driven by interferon alpha, and genetically associated with the class II HLA DQ locus.

Trutschel D, Bost P, Mariette X, Bondet V, Llibre A, Posseme C, Charbit B, Thorball CW, Jonsson R, Lessard CJ, Felten R, Ng WF, Chatenoud L, Dumortier H, Sibilia J, Fellay J, Brokstad KA, Appel S, Tarn Dr JR, Murci LQ, Mingueneau M, Meyer N, Duffy D, Schwikowski B, Gottenberg JE,

Arthritis Rheumatol. 2022 06 20;:

Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides.

Renaud F, Marion G, Loïs B, Pierre-Marie D, Marie D, Angélique F, Marion C, Laurent M, Marc A, Ahmed YS, Rose-Marie J, Alain M, Emmanuel C, Christelle S, Luc P, Jean S, Martin S, Jacques-Eric G, Jean-Hugues S

Joint Bone Spine. 2022 04 28;:105391

Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group.

Hermine O, Mariette X, Porcher R, Djossou F, Nguyen Y, Arlet JB, Savale L, Diehl JL, Georgin-Lavialle S, Cadranel J, Pialoux G, Lacombe K, Mekinian A, Gros H, Lescure X, Ghosn J, Coupez E, Grapin K, Rapp C, Michel M, Lecapitaine AL, Michot JM, Costedoat-Chalumeau N, Nguyen LBL, Semerano L, Raffi F, Aguillar C, Rouzaud C, Gottenberg JE, Hansmann Y, Bienvenu B, London J, Fantchou FS, Ackermann F, Gros A, Morel A, Gambier N, Sène D, Mégarbane B, Azoulay E, Bureau S, Dougados M, Emmerich J, Fartoukh M, Guidet B, Humbert M, Mahevas M, Pène F, Schlemmer F, Pourcher-Martinez V, Tibi A, Baron G, Perrodeau E, Baron S, Steg G, Yazdapanah Y, Simon T, Resche-Rigon M, Tharaux PL, Ravaud P

EClinicalMedicine. 2022 Apr;46:101362

Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison.

Baldini C, Arnaud L, Avčin T, Beretta L, Bellocchi C, Bouillot C, Burmester GR, Cavagna L, Cutolo M, de Vries-Bouwstra J, Doria A, Ferro F, Fonseca JE, Fonzetti S, Fulvio G, Galetti I, Gottenberg JE, Hachulla E, Krieg T, La Rocca G, Martin T, Matucci-Cerinic M, Moinzadeh P, Montecucco C, Mosca M, Mouthon L, Müller-Ladner U, Rednic S, Smith V, Talarico R, van Laar JM, Vieira A, Romão VC, Mariette X

Clin Exp Rheumatol. 2022 Mar 21;:

Do JAK inhibitors affect immune response to COVID-19 vaccination? Data from the MAJIK-SFR Registry.

Seror R, Camus M, Salmon JH, Roux C, Dernis E, Basch A, Germain V, Leske C, Brousseau S, Truchetet ME, Ramon A, Gottenberg JE, Felten R, Coury F, Colombey A, Prati C, Mariette X, Avouac J

Lancet Rheumatol. 2021 Oct 6;:

B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics.

Felten R, Duret PM, Bauer E, Sedmak N, Djossou JH, Bensalem M, Ardizzone M, Geoffroy M, Fan A, Couderc M, Salmon JH, Messer L, Javier RM, Meyer A, Chatelus E, Sordet C, Pijnenburg L, Fort J, Rinagel M, Walther J, Fabre C, Arnaud L, Sibilia J, Meyer N, Berenbaum F, Chary-Valckenaere I, Soubrier M, Sellam J, Gottenberg JE

Ann Rheum Dis. 2021 Sep 23;:

Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.

Felten R, Scherlinger M, Guffroy A, Poindron V, Meyer A, Giannini M, Korganow AS, Sordet C, Chatelus E, Javier RM, Meyer A, Pijnenburg L, Kleinmann JF, Gottenberg JE, Sibilia J, Martin T, Arnaud L

Arthritis Res Ther. 2021 07 13;23(1):188

Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection.

Scherlinger M, Felten R, Gallais F, Nazon C, Chatelus E, Pijnenburg L, Mengin A, Gras A, Vidailhet P, Arnould-Michel R, Bibi-Triki S, Carapito R, Trouillet-Assant S, Perret M, Belot A, Bahram S, Arnaud L, Gottenberg JE, Fafi-Kremer S, Sibilia J

Infect Dis Ther. 2021 Jul 10;:

Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patients.

Levy D, Nespola B, Giannini M, Felten R, Severac F, Varoquier C, Rinagel M, Korganow AS, Martin T, Poindron V, Maurier F, Chereih H, Bouldoires B, Hervier B, Lenormand C, Chatelus E, Geny B, Sibilia J, Arnaud L, Gottenberg JE, Meyer A

Rheumatology (Oxford). 2021 May 11;:

Prevalence of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and spatial association with quarries in a French Northeast region.

Giorgiutti S, Dieudonne Y, Hinschberger O, Nespola B, Campagne J, Rakotoarivelo HN, Hannedouche T, Moulin B, Blaison G, Weber JC, Dalmas MC, De Blay F, Lipsker D, Chantrel F, Gottenberg JE, Dimitrov Y, Imhoff O, Gavand PE, Andres E, Debry C, Hansmann Y, Klein A, Lohmann C, Mathiaux F, Guffroy A, Poindron V, Martin T, Korganow AS, Arnaud L

Arthritis Rheumatol. 2021 Apr 21;:

High BTLA Expression Likely Contributes to Contraction of the Regulatory T Cell Subset in Lupus Disease.

Aubergeon L, Sawaf M, Felten R, Gottenberg JE, Dumortier H, Monneaux F

Front Immunol. 2021 ;12:767099

Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.

Felten R, Devauchelle-Pensec V, Seror R, Duffau P, Saadoun D, Hachulla E, Pierre Yves H, Salliot C, Perdriger A, Morel J, Mékinian A, Vittecoq O, Berthelot JM, Dernis E, Le Guern V, Dieudé P, Larroche C, Richez C, Martin T, Zarnitsky C, Blaison G, Kieffer P, Maurier F, Dellal A, Rist S, Andres E, Contis A, Chatelus E, Sordet C, Sibilia J, Arnold C, Tawk MY, Aberkane O, Holterbach L, Cacoub P, Saraux A, Mariette X, Meyer N, Gottenberg JE

Ann Rheum Dis. 2020 Nov 18;:

Prevalence, risk factors and proteomic bioprofiles associated with heart failure in rheumatoid arthritis: The RA-HF study.

Ferreira MB, Fonseca T, Costa R, Marinhoc A, Carvalho HC, Oliveira JC, Zannad F, Rossignol P, Gottenberg JE, Saraiva FA, Rodrigues P, Barros AS, Ferreira JP

Eur J Intern Med. 2020 Nov 6;:

Clinical spectrum and therapeutic management of auto-immune myelofibrosis: a nation-wide study of 30 cases.

Mertz P, Chalayer E, Amoura Z, Cathebras P, Chiche L, Coestedoat N, Deroux A, Diot E, Durupt S, Forestier E, Gorse A, Hudier L, Killian M, Lambotte O, Lecomte C, Ledoult E, Martinez C, Mathian A, Morin AS, Noel N, Pineton De Chambrun M, Terriou L, Sibilia J, Gottenberg JE, Korganow AS, Arnaud L, Martin T

Haematologica. 2020 May 28;:

Severe Neutropenia and Agranulocytosis Related to Antithyroid Drugs: A Study of 30 Cases Managed in A Single Reference Center.

Andrès E, Lorenzo Villalba N, Mourot-Cottet R, Maloisel F, Tebacher M, Gottenberg JE, Goichot B, Herbrecht R, Zulfiqar AA

Medicines (Basel). 2020 Mar 19;7(3):

Granulomatosis-associated myositis: High prevalence of sporadic inclusion body myositis.

Dieudonné Y, Allenbach Y, Benveniste O, Leonard-Louis S, Hervier B, Mariampillai K, Nespola B, Lannes B, Echaniz-Laguna A, Wendling D, Von Frenckell C, Poursac N, Mortier E, Lavigne C, Hinschberger O, Magnant J, Gottenberg JE, Geny B, Sibilia J, Meyer A

Neurology. 2020 03 3;94(9):e910-e920

Seasonal effect on fatigue, pain and dryness in primary Sjögren's syndrome.

Duret PM, Meyer N, Saraux A, Devauchelle-Pensec V, Seror R, Le-Guern V, Larroche C, Perdriger A, Sibilia J, Guardiolle V, Mariette X, Gottenberg JE

Arthritis Res. Ther.. 2020 Feb 24;22(1):39

Acute renal failure in systemic sclerosis revealing Goodpasture syndrome: "All that glitters is not scleroderma renal crisis".

Felten R, Nespola B, Chatelus E, Arnaud L, Gottenberg JE, Canuet M, Prinz E, Goetz J, Sibilia J

J Scleroderma Relat Disord. 2020 Feb;5(1):NP1-NP5

T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients.

Poindron V, Chatelus E, Canuet M, Gottenberg JE, Arnaud L, Gangi A, Gavand PE, Guffroy A, Korganow AS, Germain P, Sibilia J, Ghannudi SE, Martin T

Semin. Arthritis Rheum.. 2019 Jun 19;:

Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity.

Matuszak J, Blondet C, Hubelé F, Gottenberg JE, Sibilia J, Bund C, Geny B, Namer IJ, Meyer A

Rheumatology (Oxford). 2019 Mar 8;:

The classical NLRP3 inflammasome controls FADD unconventional secretion through microvesicle shedding.

Mouasni S, Gonzalez V, Schmitt A, Bennana E, Guillonneau F, Mistou S, Avouac J, Ea HK, Devauchelle V, Gottenberg JE, Chiocchia G, Tourneur L

Cell Death Dis. 2019 Feb 25;10(3):190

Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cells.

Sawaf M, Fauny JD, Felten R, Sagez F, Gottenberg JE, Dumortier H, Monneaux F

JCI Insight. 2018 Jul 12;3(13):

Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus.

Gies V, Schickel JN, Jung S, Joublin A, Glauzy S, Knapp AM, Soley A, Poindron V, Guffroy A, Choi JY, Gottenberg JE, Anolik JH, Martin T, Soulas-Sprauel P, Meffre E, Korganow AS

JCI Insight. 2018 03 8;3(5):

Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.

Salmon JH, Perotin JM, Morel J, Dramé M, Cantagrel A, Ziegler LE, Ravaud P, Sibilia J, Pane I, Mariette X, Gottenberg JE,

Rheumatology (Oxford). 2018 01 1;57(1):134-139

History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs.

Andrès E, Mourot-Cottet R, Maloisel F, Keller O, Vogel T, Séverac F, Tebacher M, Gottenberg JE, Weber JC, Kaltenbach G, Goichot B, Sibilia J, Korganow AS, Herbrecht R

J Clin Med. 2017 Sep;6(10):

Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements.

Manuel RC, Pilar BZ, Raphaèle S, Hendrika B, Simon J B, Thomas D, Jacques-Eric G, Xavier M, Elke T, Stefano B, Salvatore V, Thomas M, Wan-Fai N, Aike K, Athanasios T, Claudio V,

Rheumatology (Oxford). 2017 07 1;56(7):1245

IFN-β-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis.

Meyer A, Laverny G, Allenbach Y, Grelet E, Ueberschlag V, Echaniz-Laguna A, Lannes B, Alsaleh G, Charles AL, Singh F, Zoll J, Lonsdorfer E, Maurier F, Boyer O, Gottenberg JE, Nicot AS, Laporte J, Benveniste O, Metzger D, Sibilia J, Geny B

Acta Neuropathol.. 2017 Jun;:

A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA.

Carapito R, Gottenberg JE, Kotova I, Untrau M, Michel S, Naegely L, Aouadi I, Kwemou M, Paul N, Pichot A, Locke J, Bowman SJ, Griffiths B, Sivils KL, Sibilia J, Inoko H, Micelli-Richard C, Nocturne G, Ota M, Ng WF, Mariette X, Bahram S

Hum. Mol. Genet.. 2017 Apr;:

International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.

Kleinmann JF, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacre K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, Cacoub P, Caillard S, Chiche L, Chosidow O, Costedoat-Chalumeau N, Daien C, Daugas E, Derdèche N, Doria A, Fain O, Fakhouri F, Farge D, Gabay C, Guillo S, Hachulla E, Hajjaj-Hassouni N, Hamidou M, Houssiau FA, Jourde-Chiche N, Koné-Paut I, Ladjouz-Rezig A, Lambotte O, Lipsker D, Mariette X, Martin-Silva N, Martin T, Maurier F, Meckenstock R, Mékinian A, Meyer O, Mohamed S, Morel J, Moulin B, Mulleman D, Papo T, Poindron V, Puéchal X, Punzi L, Quartier P, Sailler L, Smail A, Soubrier M, Sparsa A, Tazi-Mezalek Z, Zakraoui L, Zuily S, Sibilia J, Gottenberg JE

Autoimmun Rev. 2017 Apr;:

Inflammatory Muscle Disease: A New Landscape.

Meyer A, Lannes B, Goetz J, Echaniz-Laguna A, Lipsker D, Arnaud L, Martin T, Gottenberg JE, Geny B, Sibilia J

Joint Bone Spine. 2017 Mar;:

Schnitzler syndrome: validation and applicability of diagnostic criteria in real-life patients.

Gusdorf L, Asli B, Barbarot S, Néel A, Masseau A, Puéchal X, Gottenberg JE, Grateau G, Blanchard-Delaunay C, Rizzi R, Lifermann F, Kyndt X, Aubin F, Bessis D, Boye T, Gayet S, Rongioletti F, Sauleau E, Fermand JP, Lipsker D

Allergy. 2017 Feb;72(2):177-182

Idiosyncratic drug-induced neutropenia & agranulocytosis.

Andrès E, Mourot-Cottet R, Maloisel F, Séverac F, Keller O, Vogel T, Tebacher M, Weber JC, Kaltenbach G, Gottenberg JE, Goichot B, Sibilia J, Korganow AS, Herbrecht R

QJM. 2017 Jan;:

Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients.

Danion F, Sparsa L, Arnaud L, Alsaleh G, Lefebvre F, Gies V, Martin T, Lukas C, Durckel J, Ardizzone M, Javier RM, Kleinmann JF, Moreau P, Blaison G, Goetz J, Chatelus E, Gottenberg JE, Sibilia J, Sordet C

RMD Open. 2017 ;3(2):e000555

Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases.

Mourot-Cottet R, Maloisel F, Séverac F, Keller O, Vogel T, Tebacher M, Weber JC, Kaltenbach G, Gottenberg JE, Goichot B, Sibilia J, Korganow AS, Herbrecht R, Andrès E

Drugs Real World Outcomes. 2016 Dec;3(4):393-399

Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial.

Gottenberg JE, Brocq O, Perdriger A, Lassoued S, Berthelot JM, Wendling D, Euller-Ziegler L, Soubrier M, Richez C, Fautrel B, Constantin AL, Mariette X, Morel J, Gilson M, Cormier G, Salmon JH, Rist S, Lioté F, Marotte H, Bonnet C, Marcelli C, Sellam J, Meyer O, Solau-Gervais E, Guis S, Ziza JM, Zarnitsky C, Chary-Valckenaere I, Vittecoq O, Saraux A, Pers YM, Gayraud M, Bolla G, Claudepierre P, Ardizzone M, Dernis E, Breban MA, Fain O, Balblanc JC, Aberkane O, Vazel M, Back C, Candon S, Chatenoud L, Perrodeau E, Sibilia J, Ravaud P

JAMA. 2016 Sep 20;316(11):1172-1180

Reduced DICER1 Expression Bestows Rheumatoid Arthritis Synoviocytes Proinflammatory Properties and Resistance to Apoptotic Stimuli.

Alsaleh G, Nehmar R, Blüml S, Schleiss C, Ostermann E, Dillenseger JP, Sayeh A, Choquet P, Dembele D, Francois A, Salmon JH, Paul N, Schabbauer G, Bierry G, Meyer A, Gottenberg JE, Haas G, Pfeffer S, Vallat L, Sibilia J, Bahram S, Georgel P

. 2016 Aug;68(8):1839-48

Occurrence of Rheumatoid Arthritis in a Patient Treated with Anakinra for Schnitzler Syndrome: A Case Report.

Margerin F, Gottenberg JE, Lipsker D

J. Rheumatol.. 2016 Jul;43(7):1447

Dermatomyositis flare on imiquimod therapy highlights a crucial role of aberrant TLR7 signalling.

Meyer A, Alsaleh G, Heuschling C, Gottenberg JE, Georgel P, Geny B, Bahram S, Sibilia J

RMD Open. 2016 ;2(2):e000294

High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis.

Bourji K, Meyer A, Chatelus E, Pincemail J, Pigatto E, Defraigne JO, Singh F, Charlier C, Geny B, Gottenberg JE, Punzi L, Cozzi F, Sibilia J

Free Radic Biol Med. 2015 Oct;87:282-9

Germline variation of TNFAIP3 in primary Sjogren's syndrome-associated lymphoma.

Nocturne G, Tarn J, Boudaoud S, Locke J, Miceli-Richard C, Hachulla E, Dubost JJ, Bowman S, Gottenberg JE, Criswell LA, Lessard CJ, Sivils KL, Carapito R, Bahram S, Seror R, Ng WF, Mariette X

Ann Rheum Dis. 2015 Sep 2. pii: annrheumdis-2015-207731

Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study.

Bauer H, Luxembourger C, Gottenberg JE, Fournier S, Abravanel F, Cantagrel A, Chatelus E, Claudepierre P, Hudry C, Izopet J, Fabre S, Lefevre G, Marguerie L, Martin A, Messer L, Molto A, Pallot-Prades B, Pers YM, Roque-Afonso AM, Roux C, Sordet C, Soubrier M, Veissier C, Wendling D, Péron JM, Sibilia J,

Medicine (Baltimore). 2015 Apr;94(14):e675

Eosinophilic myositis as first manifestation in a patient with type 2 myotonic dystrophy CCTG expansion mutation and rheumatoid arthritis.

Meyer A, Lannes B, Carapito R, Bahram S, Echaniz-Laguna A, Geny B, Sibilia J, Gottenberg JE

Neuromuscul Disord. 2015 Feb;25(2):149-52

B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis.

Francois A, Gombault A, Villeret B, Alsaleh G, Fanny M, Gasse P, Adam SM, Crestani B, Sibilia J, Schneider P, Bahram S, Quesniaux V, Ryffel B, Wachsmann D, Gottenberg JE, Couillin I

J Autoimmun. 2015 Jan;56:1-11

Incidence and prevalence of inflammatory myopathies: a systematic review.

Meyer A, Meyer N, Schaeffer M, Gottenberg JE, Geny B, Sibilia J

Rheumatology (Oxford). 2015 Jan;54(1):50-63

Nanostructured thick 3D nanofibrous scaffold can induce bone.

Eap S, Morand D, Clauss F, Huck O, Stoltz JF, Lutz JC, Gottenberg JE, Benkirane-Jessel N, Keller L, Fioretti F

Biomed Mater Eng. 2015;25(1 Suppl):79-85

Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjogren's syndrome.

Gong YZ, Nititham J, Taylor K, Miceli-Richard C, Sordet C, Wachsmann D, Bahram S, Georgel P, Criswell LA, Sibilia J, Mariette X, Alsaleh G, Gottenberg JE

J Autoimmun. 2014 Jun;51:57-66

MiR-30a-3p negatively regulates BAFF synthesis in systemic sclerosis and rheumatoid arthritis fibroblasts.

Alsaleh G, Francois A, Philippe L, Gong YZ, Bahram S, Cetin S, Pfeffer S, Gottenberg JE, Wachsmann D, Georgel P, Sibilia J

PLoS One. 2014 Oct 31;9(10):e111266

B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis.

Francois A, Chatelus E, Wachsmann D, Sibilia J, Bahram S, Alsaleh G, Gottenberg JE

Arthritis Res Ther. 2013 Oct 28;15(5):R168

Cognitive Dysfunction and Dementia in Primary Sjogren's Syndrome.

Blanc F, Longato N, Jung B, Kleitz C, Di Bitonto L, Cretin B, Collongues N, Sordet C, Fleury M, Poindron V, Gottenberg JE, Anne O, Lipsker D, Martin T, Sibilia J, de Seze J

ISRN Neurol. 2013 Sep 19;2013:501327